AWMDMG
AEGR

Austin W. Marxe & David M. Greenhouse’s Aegerion Pharmaceuticals AEGR Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,100
Closed -$324K – 154
2014
Q2 		$324K Buy
+10,100
New +$376K 0.04% 130

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's AEGR Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2014, closing a stake of 10,100 shares — an estimated $324K sold.

Austin W. Marxe & David M. Greenhouse first reported a position in AEGR in Q2 2014 and held it in 1 quarter. The position peaked at $324K in Q2 2014. 131 funds tracked by Wall St. Rank hold AEGR as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse reported no remaining Aegerion Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Austin W. Marxe & David M. Greenhouse sold 10,100 Aegerion Pharmaceuticals shares in Q3 2014, an estimated $324K.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Aegerion Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Austin W. Marxe & David M. Greenhouse's Aegerion Pharmaceuticals position peaked at $324K in Q2 2014.
  • 131 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.